News

Voluntary Recall Notice for BD PosiFlush™ SF Saline Flush Syringes

Industry News & Research

BD is conducting a voluntary medical device recall for multiple lots of the BD PosiFlush™ SF (Sterile Field) Saline Flush Syringe 10mL identified…

Read More

CDC Calls for Stakeholder Comments on Pain, Pain Management and Opioid Use

Industry News & Research

The Centers for Disease Control and Prevention (CDC) are currently soliciting written comments on pain and pain management, including those relevant to…

Read More

Voluntary Recall Notice for BD PosiFlush™ SF Saline Flush Syringes

Industry News & Research

BD is conducting a voluntary medical device recall for multiple lots of the BD PosiFlush™ SF (Sterile Field) Saline Flush Syringe 10mL identified…

Read More

Comment Period for VWD Clinical Practice Guidelines Open

Industry News & Research

The National Hemophilia Foundation (NHF)  is seeking comments on draft ASH, ISTH, NHF and WHF clinical practice guidelines on VWD Diagnosis &…

Read More

MASAC Issues Four New Documents

Industry News & Research

The National Hemophilia Foundation’s (NHF’s) Medical and Scientific Advisory Council (MASAC) issued four new documents, which were adopted by NHF’s Board of…

Read More

Three Concizumab Trials Halted by Novo Nordisk

Industry News & Research

Novo Nordisk recently announced that they have “paused” three clinical trials for their investigational subcutaneous therapy concizumab. The therapy is developed using…

Read More

Takeda Responds to HFA-NHF Letter on VONVENDI Recall

Industry News & Research

As previously reported by HFA and NHF, Takeda announced the recall of two lots of VONVENDI von Willebrand factor (recombinant) 1,300 I.U….

Read More

Medexus Acquires XINITY® from Aptevo

Industry News & Research

Aptevo Theraoeutics has sold their recombinant factor IX product IXINITY® to Canada-based Medexus Pharmaceuticals. IXINITY®, which first received approval from the U.S….

Read More

Partners in Bleeding Disorders Education Program Launches Revised Module

Industry News & Research

The Partners in Bleeding Disorders Education Program has announced the launch a new version of “Understanding Hemophilia,” a six-part online learning activity for clinicians…

Read More

Emergency Department Guidelines Now Available in Multiple Formats

Industry News & Research

It is critical that an individual with a bleeding disorder who presents in an emergency department (ED) be triaged and administered care…

Read More

NHF, WFH, EHC Monitor Coronavirus Impact on Bleeding Disorders Community

Industry News & Research

The National Hemophilia Foundation (NHF) has been monitoring the latest information on the current coronavirus (2019-nCoV) as it pertains to the bleeding…

Read More

Novo Nordisk Announces Launch of New Factor VIII Therapy

Industry News & Research

Novo Nordisk has announced the launch of ESPEROCT®, the company’s long-acting recombinant factor VIII product for the prevention and treatment of bleeding…

Read More

Medscape Launches Activity for Emergency Department Providers

Industry News & Research

An important new educational activity has launched for healthcare providers who practice in an emergency department setting. “Evaluation and Management of Hemophilia…

Read More

FDA Releases Guidance Documents for Gene Therapies

Industry News & Research

The U.S. Food and Drug Administration (FDA) has released several new gene therapy guidance documents to provide “regulatory clarity” for developers of…

Read More

Patient Groups Urge Supreme Court to Swiftly Take Up Health Care Case

Industry News & Research

Washington, D.C.—January 15, 2020— Patient and health advocacy groups representing millions of Americans with pre-existing conditions will file an amicus curiae or friend of the…

Read More

NHF’s 72nd Bleeding Disorders Conference

Industry News & Research

Please join us at NHF’s Bleeding Disorders Conference, August 6-8, 2020 in Atlanta, Georgia. Registration is now open! New this year! We…

Read More

Study Shows Higher Postpartum Hemorrhage in FXI Deficiency Patients Post Cesarean

Industry News & Research

Researchers from the Beth Israel Deaconess Medical Center in Boston, MA conducted a study on the link between postpartum hemorrhage (PPH) and…

Read More

Could a Cure for Hemophilia Be Personalized?

Industry News & Research, Living with a Bleeding Disorder

Has your hematologist ever asked that your child have pharmacokinetic (PK) testing? Chances are, the doctor wants to know how factor behaves…

Read More

UniQure Announces Interim Hemophilia B Gene Therapy Trial Data

Industry News & Research

uniQure recently announced interim clinical trial data related to a phase IIb clinical study of etranacogene dezaparvovec (AMT-061), the company’s investigational gene…

Read More

Two Gene Therapy Medscape Activities Recertified

Gene Therapy, Industry News & Research, Living with a Bleeding Disorder

The National Hemophilia Foundation (NHF) is pleased to announce that two educational activities in the “Clinical Advances in Gene Therapy for Hemophilia”…

Read More

Study Will Examine Brain Development in Young People with Hemophilia

Industry News & Research

A new observational study funded by Novo Nordisk, which is currently in the recruitment phase, will seek to better understand how hemophilia…

Read More

NHF and HFA Letter to Genentech Announcement of Particulate Matter in Emicizumab (HEMLIBRA)

Industry News & Research

October 10, 2019 The National Hemophilia Foundation and the Hemophilia Federation of America continue to follow up on issues arising from Genentech’s recent…

Read More

Octapharma’s Wilate® Receives Expanded Approval from FDA

Industry News & Research

October 9, 2019 Octapharma recently announced that their plasma-derived von Willebrand Factor (VWF)/Factor VIII (FVIII) product Wilate®, was approved by the U.S….

Read More

Genentech Issues Statement on Hemlibra Particles; MASAC Responds

Industry News & Research

October 7, 2019 Today, Genentech provided the following statement regarding reports of particulate matter in vials of Hemlibra. You can read Genentech’s…

Read More